Biotechnology Assets, S.A. (BST:041)

Germany flag Germany · Delayed Price · Currency is EUR
0.2530
+0.0110 (4.55%)
At close: Apr 28, 2026
Market Cap19.76M -8.0%
Revenue (ttm)3.05M -9.5%
Net Income-2.08M
EPSn/a
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.2420
Previous Close0.2420
Day's Range0.2420 - 0.2710
52-Week Range0.1130 - 0.5240
Betan/a
RSI68.24
Earnings DateApr 21, 2026

About Biotechnology Assets

Biotechnology Assets, S.A. develops and markets biotechnological assets for applications in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a protein engineering tool that allows the conjugation of proteins through the formation of new peptide bonds; universal switchable split-chimeric antigen receptor (CAR); VACC-ZERA technology, a tool to generate recombinant proteins in microparticles suited for therapeutic and prophylactic adjuvant free vaccines administer... [Read more]

Industry Pharmaceutical Preparations
CEO Jaime Feced Rubio
Employees 30
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol 041

Financial Performance

Financial Statements